Literature DB >> 8177238

Antibodies to laminin and immunohistochemical localization of laminin in chronic chagasic cardiomyopathy: a review.

J Milei1, J Sánchez, R Storino, Z X Yu, B Denduchis, V J Ferrans.   

Abstract

Antibodies against laminin were determined by ELISA in forty six patients suffering from Chagas' disease and twenty healthy persons (control group). The patients were divided into three groups according to the severity of clinical, electrocardiographic and echocardiographic studies. Histologic, ultrastructural and immunohistochemical studies were made of endomyocardial biopsy specimens from 10 of these patients with chronic Chagasic cardiomyopathy. Antibodies to laminin were detected in 50% of the patients in each of the three groups. However analysis of the data did not allow us to determine any significant correlation among the severity of the different clinical and non-invasive studies and the level of circulating antibodies to laminin. The highest titers of antilaminin antibodies were detected in the group with severe cardiological alterations (37% of the patients). Histological and electron microscopic observation of myocardial biopsies disclosed marked thickening of the basement membranes of the myocytes, endothelial cells and vascular smooth muscle cells. Light (peroxidase-labeled antibodies) and electron (gold-conjugated antibody) microscopic immunohistochemical methods revealed a positive reaction for laminin in these thickened basement membranes. This thickening may develop as a consequence of: a) an immunologic reaction which is triggered by the presence of a laminin-like molecule on the surfaces of T. cruzi amastigotes and trypomastigotes; b) an immunologic response to direct injury of basement membranes causing some of their components to become antigenic; c) myocardial fibrosis, with synthesis of new connective tissue components, and d) a combination of the preceding factors. The relationship of these changes to antilaminin antibodies remains unclear.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8177238     DOI: 10.1007/bf00926364

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Laminin in chagasic autoimmunity?

Authors:  J Milei; R A Storiño
Journal:  Parasitol Today       Date:  1987-04

Review 2.  Natural anti-Gal antibodies prevent, rather than cause, autoimmunity in human Chagas' disease.

Authors:  R T Gazzinelli
Journal:  Res Immunol       Date:  1991-02

3.  Antibodies to laminin in preeclampsia.

Authors:  J M Foidart; J Hunt; C M Lapiere; B Nusgens; C De Rycker; M Bruwier; R Lambotte; A Bernard; P Mahieu
Journal:  Kidney Int       Date:  1986-05       Impact factor: 10.612

4.  [The pathology of Chagas disease in man].

Authors:  Z A Andrade
Journal:  Ann Soc Belg Med Trop       Date:  1985

Review 5.  Laminin and other basement membrane components.

Authors:  G R Martin; R Timpl
Journal:  Annu Rev Cell Biol       Date:  1987

6.  Immunohistochemical localization of laminin in the hearts of patients with chronic chagasic cardiomyopathy: relationship to thickening of basement membranes.

Authors:  J A Sanchez; J Milei; Z X Yu; R Storino; R Wenthold; V J Ferrans
Journal:  Am Heart J       Date:  1993-12       Impact factor: 4.749

7.  Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein.

Authors:  J M Foidart; E W Bere; M Yaar; S I Rennard; M Gullino; G R Martin; S I Katz
Journal:  Lab Invest       Date:  1980-03       Impact factor: 5.662

Review 8.  Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance.

Authors:  S R Milani; L R Travassos
Journal:  Braz J Med Biol Res       Date:  1988       Impact factor: 2.590

9.  Clustering of cell surface laminin enhances its association with the cytoskeleton.

Authors:  R L Cody; M S Wicha
Journal:  Exp Cell Res       Date:  1986-07       Impact factor: 3.905

10.  Anti-basement membrane glomerulopathy in experimental trypanosomiasis.

Authors:  J A Bruijn; B S Oemar; J H Ehrich; J M Foidart; G J Fleuren
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

View more
  8 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  REGULATION of the EXTRACELLULAR MATRIX INTERACTOME by Trypanosoma cruzi.

Authors:  Tatiana C Cardenas; Candice A Johnson; Siddharth Pratap; Pius N Nde; Vyacheslav Furtak; Yuliya Y Kleshchenko; Maria F Lima; Fernando Villalta
Journal:  Open Parasitol J       Date:  2010

3.  Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection.

Authors:  Pius N Nde; Kaneatra J Simmons; Yuliya Y Kleshchenko; Siddharth Pratap; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

4.  Cardiac myosin autoimmunity in acute Chagas' heart disease.

Authors:  J S Leon; L M Godsel; K Wang; D M Engman
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Gene network analysis during early infection of human coronary artery smooth muscle cells by Trypanosoma cruzi and Its gp83 ligand.

Authors:  Pius N Nde; Candice A Johnson; Siddharth Pratap; Tatiana C Cardenas; Yuliya Y Kleshchenko; Vyacheslav A Furtak; Kaneatra J Simmons; Maria F Lima; Fernando Villalta
Journal:  Chem Biodivers       Date:  2010-05       Impact factor: 2.408

6.  BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.

Authors:  Daniela A Bermejo; María C Amezcua-Vesely; Carolina L Montes; María C Merino; Ricardo C Gehrau; Hugo Cejas; Eva V Acosta-Rodríguez; Adriana Gruppi
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

Review 7.  Molecular analysis of early host cell infection by Trypanosoma cruzi.

Authors:  Fernando Villalta; M Nia Madison; Yuliya Y Kleshchenko; Pius N Nde; Maria F Lima
Journal:  Front Biosci       Date:  2008-05-01

8.  Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection.

Authors:  Pius N Nde; Maria F Lima; Candice A Johnson; Siddharth Pratap; Fernando Villalta
Journal:  Front Immunol       Date:  2012-11-06       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.